GEN Exclusives

More »

GEN News Highlights

Back to Item »

First DPP-4 Inhibitor in the U.S. Approved for Type 2 Diabetes

Merck & Co.’s drug indicated as a monotherapy and as an add-on to either metformin or TZDs.

Forward this item to a colleague:


(Separate multiple addresses by commas)


(Separate multiple addresses by commas)


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Cancer Drug Approvals and Efficacy

Do you think regulatory agencies should be required to provide stronger evidence of the clinical effectiveness of cancer drugs, including a greater emphasis on patient survival time?

More »